187 related articles for article (PubMed ID: 8543909)
21. Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells. Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake.
Lamberg-Allardt C; Valtonen E; Polojärvi M; Stewen P
Mol Cell Endocrinol; 1991 Oct; 81(1-3):25-31. PubMed ID: 1665829
[TBL] [Abstract][Full Text] [Related]
22. Systemic effects of 1,25-dihydroxyvitamin D3 on the pituitary-hypothalamic axis in rats.
Törnquist K; Lamberg-Allardt C
Acta Endocrinol (Copenh); 1987 Jun; 115(2):225-8. PubMed ID: 3111137
[TBL] [Abstract][Full Text] [Related]
23. Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor.
Han B; Tashjian AH
Mol Endocrinol; 1995 Dec; 9(12):1708-19. PubMed ID: 8614407
[TBL] [Abstract][Full Text] [Related]
24. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
[TBL] [Abstract][Full Text] [Related]
25. Thyrotropin-releasing hormone receptors in the pituitary of rainbow trout (Oncorhynchus mykiss).
Schwartzentruber RS; Omeljaniuk RJ
Gen Comp Endocrinol; 1995 Feb; 97(2):209-19. PubMed ID: 7622016
[TBL] [Abstract][Full Text] [Related]
26. Effects of vitamin D3 metabolites on thyrotropin secretion from rat pituitary cells in culture.
Törnquist K; Forss L; Lamberg-Allardt C
J Endocrinol Invest; 1990 May; 13(5):391-5. PubMed ID: 2380504
[TBL] [Abstract][Full Text] [Related]
27. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
Griffin JE; Zerwekh JE
J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754
[TBL] [Abstract][Full Text] [Related]
28. Calcitriol attenuates the thyrotropin-releasing hormone-stimulated inositol phosphate production in clonal rat pituitary (GH4C1) cells.
Sørnes G; Haug E; Torjesen PA
Mol Cell Endocrinol; 1993 Jun; 93(2):149-56. PubMed ID: 8349024
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
30. Direct effects of vitamin D3 analogues on G-protein mediated signalling systems in rat osteosarcoma cells and rat pituitary adenoma cells.
Mortensen BM; Lund HW; Jablonski G; Paulssen RH; Gordeladze JO
Biosci Rep; 1995 Jun; 15(3):135-50. PubMed ID: 7579039
[TBL] [Abstract][Full Text] [Related]
31. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
[TBL] [Abstract][Full Text] [Related]
32. Intraventricular administration of thyrotrophin-releasing hormone (TRH) suppresses prolactin secretion and synthesis: a possible involvement of dopamine release by TRH from rat hypothalamus.
Ikegami H; Jikihara H; Koike K; Morishige K; Kurachi H; Yamamoto N; Hirota K; Miyake A; Tanizawa O
J Endocrinol; 1992 Apr; 133(1):59-66. PubMed ID: 1355520
[TBL] [Abstract][Full Text] [Related]
33. Effects of 1,25-dihydroxyvitamin D3 and phorbol ester on 25-hydroxyvitamin D3 24-hydroxylase cytochrome P450 messenger ribonucleic acid levels in primary cultures of rat renal cells.
Chen ML; Boltz MA; Armbrecht HJ
Endocrinology; 1993 Apr; 132(4):1782-8. PubMed ID: 7681765
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 25-hydroxyvitamin D3-26,23-lactone but not 24,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3 in opossum kidney cells treated with 1 alpha, 25-dihydroxyvitamin D3.
Horiuchi N; Saikatsu S; Akeno N; Abe M; Kimura S; Yamada S
Horm Metab Res; 1995 Feb; 27(2):83-9. PubMed ID: 7759063
[TBL] [Abstract][Full Text] [Related]
35. 1,25-dihydroxyvitamin D3 attenuates TSH and 8-(4-chlorophenylthio)-cAMP-stimulated growth and iodide uptake by rat thyroid cells (FRTL-5).
Berg JP; Torjesen PA; Haug E
Thyroid; 1993; 3(3):245-51. PubMed ID: 8257867
[TBL] [Abstract][Full Text] [Related]
36. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
37. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
38. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells.
Petkovich PM; Heersche JN; Tinker DO; Jones G
J Biol Chem; 1984 Jul; 259(13):8274-80. PubMed ID: 6330107
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3.
Prehn JL; Fagan DL; Jordan SC; Adams JS
Blood; 1992 Dec; 80(11):2811-6. PubMed ID: 1450407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
